Shizuoka, Japan

Mikimasa Tanada

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 6.8

ph-index = 4

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Mikimasa Tanada: Innovator in Peptide Compound Research

Introduction

Mikimasa Tanada is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of peptide compounds, holding a total of 7 patents. His work focuses on developing novel methods for drug discovery and peptide compound cyclization.

Latest Patents

Tanada's latest patents include a peptide-compound cyclization method aimed at discovering drugs effective for challenging targets. This invention provides innovative methods for cyclizing peptide compounds, along with novel peptide compounds and libraries that facilitate drug discovery. Another notable patent involves a cyclic peptide compound with Kras inhibitory action. In this work, Tanada and his team identified cyclic peptide compounds that interact with Ras and discovered non-natural amino acids useful for producing these compounds. They also found that these cyclic peptide compounds inhibit the binding between Ras and SOS.

Career Highlights

Mikimasa Tanada is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company. His research has significantly advanced the understanding of peptide compounds and their potential applications in drug development.

Collaborations

Tanada has collaborated with notable colleagues, including Takashi Emura and Atsushi Matsuo, to further enhance the research and development of peptide compounds.

Conclusion

Mikimasa Tanada's innovative work in peptide compound research has the potential to revolutionize drug discovery and development. His contributions continue to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…